Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Director departure
Appointed director
GeoVax Labs, Inc. (GOVX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 Second Quarter Financial Results and Provides Corporate Update"
08/02/2023 8-K Quarterly results
07/18/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: " ",
" "
06/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
05/05/2023 8-K Quarterly results
Docs: "GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update"
03/24/2023 8-K Quarterly results
Docs: "GeoVax Reports 2022 Year-End Financial Results And Provides Corporate Update"
12/09/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
12/08/2022 8-K Appointed a new director
Docs: "2023 Stock Incentive Plan",
"GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors"
11/14/2022 8-K Quarterly results
Docs: "GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
09/01/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "GeoVax Announces Addition to its Board of Directors"
09/01/2022 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
08/04/2022 8-K Quarterly results
Docs: "FINANCIAL TABLES FOLLOW MORE GEOVAX LABS, INC. Condensed Consolidated Statements of Operations Information",
"Conference Call Transcript",
"Conference Call Slide Presentation"
05/27/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
Docs: "GeoVax Reports 2022 First Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
03/10/2022 8-K Quarterly results
Docs: "GeoVax Reports 2021 Year-End Financial Results And Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
01/20/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Securities Purchase Agreement",
"Registration Rights Agreement",
"Form of Pre-Funded Warrant",
"Form of Common Warrant",
"GeoVax Announces $10 Million Private Placement",
"GeoVax Announces Closing of $10 Million Private Placement"
01/04/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Goal Achievement #1"
12/15/2021 8-K Quarterly results
11/12/2021 8-K Quarterly results
Docs: "GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update",
"Conference Call Transcript",
"Conference Call Slide Presentation"
11/10/2021 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Exclusive License Agreement, by and between GeoVax, Inc. and City of Hope",
"GeoVax and City of Hope Announce Agreement to Accelerate Development and Commercialization for City of Hope’s COVID-19 Vaccine"
09/30/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Gedeptin® License Conference Call Transcript",
"Gedeptin® License Conference Call Slide Presentation"
09/29/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Warrant issued to PNP Therapeutics, Inc.",
"Assignment and License Agreement, by and between GeoVax, Inc. and PNP Therapeutics, Inc.",
"GeoVax Expands Immuno-Oncology Pipeline with Acquisition of Clinical-Stage Cancer Program"
08/20/2021 8-K Quarterly results
08/11/2021 8-K Quarterly results
05/07/2021 8-K Quarterly results
03/23/2021 8-K Quarterly results
Docs: "GeoVax Reports 2020 Year-End Financial Results And Provides Corporate Update"
02/11/2021 8-K Quarterly results
02/11/2021 8-K Quarterly results
11/30/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Patent and Biological Materials License Agreement for Internal Research Use with the National Institute of Allergy and Infectious Diseases,",
"###"
11/05/2020 8-K Quarterly results
Docs: "GeoVax Reports 2020 Third Quarter Financial Results and Provides Corporate Update"
10/26/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Patent and Biological Materials License Agreement with the National Institute of Allergy and Infectious Diseases,",
"Press release"
09/29/2020 8-K Quarterly results
09/25/2020 8-K Quarterly results
08/26/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy